viewIofina PLC

Iofina's house broker leaves forecasts unchanged after China dumping decision

In the autumn of 2017, Iofina and other foreign suppliers of hydriodic acid (HI) into China were accused of dumping HI by a relatively new Chinese HI manufacturer; China's Ministry of Commerce has upheld this claim in a preliminary determination

IOsorb plant
"The ramp-up of its new IO#7 unit progresses well, helping to drive growth, lower costs and improve profitability," finnCap said

Iofina plc (LON:IOF) has reiterated its 2018 production guidance but advised profits would take a small hit as China gets tough on hydriodic acid imports.

Iofina revealed that a preliminary determination from China's Ministry of Commerce (MOFCOM) regarding an Iofina Chemical product, namely hydriodic acid (HI), concluded that Iofina Chemical and the other HI manufacturers from the USA and Japan, had been selling HI in China at below market value.

READ: Iofina expecting increase in production as IO#7 plant scales-up operations

Preliminary dumping duties of 118.8% and 41.1% have been imposed with immediate effect against USA and Japanese importers respectively. Iofina believes this preliminary determination and the tariff imposed is incorrect and will investigate all means to reverse this decision before the final determination in the autumn of this year.

Given the recent deterioration of the USA-China trade relationship, the conclusion on the matter is unclear, Iofina said. Its best guess at the moment is that there will be a small negative effect on profitability of slightly more than US$100,000 from the board's current expectations in 2018.

“The preliminary determination in the hydriodic acid anti-dumping inquiry in China is extremely disappointing. We continue to refute these claims and will investigate and pursue all options to remedy the situation," said Dr Tom Becker, the president and chief executive officer of Iofina.

On the plus side, Iofina expects to produce 260-265 tonnes of its IOflo crystalline iodine in the first half of 2018 and 315-340 tonnes in the second half of the year; in the whole of 2017 the company produced 503 tonnes of crystalline iodine so this represents a big increase and assumes no contribution from IO#5, where management is pondering options to optimise production from this plant.

Furthermore, spot prices continue to strengthen for iodine and are trading on or above the US$25/kg level for large volume purchases.

''Our IOsorb plants are performing well and we are pleased that our expected production of near 600MT [metric tons] of crystalline iodine in 2018 is in line with analyst predictions in the market. The production from IO#7 has resulted in a lowering of our total per unit iodine production costs and this coupled with higher iodine prices and an increase in year-on-year production are all positive for Iofina's profitability,” Dr Becker said.

House broker not overly concerned by Chinese issue​

House broker finnCap said the effect of the Chinese ruling will be small, accounting for less than 3% of projected underlying earnings, and that it saw no need to alter its forecasts.

“More important drivers for 2018 earnings will be the iodine, which continues to improve, further production increases from IO#7 and whether IO#5 returns to production,” the broker said.

Shares were down 3.7% at 15.5p in mid-morning trading.

--- adds broker comment and share price ---

Quick facts: Iofina PLC

Price: 12.75 GBX

Market: LSE
Market Cap: £24.46 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Iofina PLC named herein, including the promotion by the Company of Iofina PLC in any Content on the Site, the Company receives from said issuer...


'Things are adding up for Iofina' with increased year-on-year production

Tom Becker, chief executive of Iofina plc (LON:IOF), tells Proactive Investors 2017 was a year of 'substantial' progress for the company. Gross profit increased by US$2.2m from US$2.7mln to US$4.9mln while underlying earnings (EBITDA) improved by US$2.7m from a deficit of US$1.3mln to a...

on 30/4/18

3 min read